Impact of botulinum toxin type A on disability and career burden due to arm spasticity after stroke

Completed

Phase N/A Results

Summary of Purpose

To investigate the impact of botulinum toxin type A (BT-A) treatment on disability and caregiver burden in patients with arm spasticity after stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 14 August 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Northern and Yorkshire Regional Health Authority and Ipsen Ltd.

Trial Design

Randomized, double-blind, parallel trial of 40 patients at a single center.

Contacts

Not available